World's Best Scientists 2026 revealed!
Osamu Yokosuka

Osamu Yokosuka

D-Index & Metrics

Medicine

D-Index
94
Citations
41934
World Ranking
10317
National Ranking
286

Osamu Yokosuka publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Osamu Yokosuka sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 997 publications — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Osamu Yokosuka D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Osamu Yokosuka sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 94 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Osamu Yokosuka is affiliated with Chiba University in Japan and has a research focus grounded in the field of Medicine with a specialization in Hepatology. Their academic contributions encompass a broad scope of liver-related medical research, particularly regarding liver disease diagnosis, treatment, and transplantation.

Their work spans several key subfields including Hepatology, Epidemiology, Surgery, Pulmonary and Respiratory Medicine, and Oncology. Main topical areas covered by their research include:

  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Liver Diseases and Immunity
  • Hepatitis C virus research
  • Hepatitis B Virus Studies
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatitis Viruses Studies and Epidemiology

Osamu Yokosuka has frequently published in several specialized venues, with a notable presence in:

  • Hepatology International
  • Hepatology Research
  • Journal of Hepatology
  • Liver International
  • Cancer Medicine

Their recent scholarly papers include:

  • Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study), 2020, Hepatology International
  • APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis, 2022, Hepatology International
  • APASL practical recommendations for the management of hepatocellular carcinoma in the era of COVID-19, 2020, Hepatology International
  • Comparative accuracy of prognostic models for short-term mortality in acute-on-chronic liver failure patients: CAP-ACLF, 2021, Hepatology International
  • Analyses of Intermediate-Stage Hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization prior to Designing Clinical Trials, 2020, Liver Cancer

The scientist has collaborated extensively with a group of frequent co-authors including Shiv Kumar Sarin, George Lau, Naoya Kato, Sombat Treeprasertsuk, and Rino Alvani Gani.

Best Publications

  • Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial

    Jordi Bruix;Shukui Qin;Philippe Merle;Alessandro Granito

  • Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan

    Haruhiko Yoshida;Yasushi Shiratori;Mitsuhiko Moriyama;Yasuyuki Arakawa

  • Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)

    Shiv Kumar Sarin;Ashish Kumar;John A. Almeida;Yogesh Kumar Chawla

  • Histologic Improvement of Fibrosis in Patients with Hepatitis C Who Have Sustained Response to Interferon Therapy

    Yasushi Shiratori;Fumio Imazeki;Mitsuhiko Moriyama;Michitami Yano

  • Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties.

    Tetsuhiro Chiba;Kaoru Kita;Yun-Wen Zheng;Osamu Yokosuka

  • Mutations in the Precore Region of Hepatitis B Virus DNA in Patients with Fulminant and Severe Hepatitis

    Masao Omata;Toshiki Ehata;Osamu Yokosuka;Kazuhiko Hosoda

  • Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease

    Hajime Sumi;Osamu Yokosuka;Naohiko Seki;Makoto Arai

  • Incidence of hepatocellular carcinoma in chronic Hepatitis B and C: A prospective study of 251 patients

    Susumu Takano;Osamu Yokosuka;Fumio Imazeki;Masami Tagawa

  • Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial.

    Masatoshi Kudo;Kazuomi Ueshima;Masafumi Ikeda;Takuji Torimura

  • New Inuyama classification; new criteria for histological assessment of chronic hepatitis

    Fumihiro Ichida;Takao Tsuji;Masao Omata;Takafumi Ichida

  • Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial.

    Masashi Mizokami;Osamu Yokosuka;Tetsuo Takehara;Naoya Sakamoto

  • Antiviral Therapy for Cirrhotic Hepatitis C: Association with Reduced Hepatocellular Carcinoma Development and Improved Survival

    Yasushi Shiratori;Yoichi Ito;Osamu Yokosuka;Fumio Imazeki

  • Interferon therapy prolonged life expectancy among chronic hepatitis C patients.

    Haruhiko Yoshida;Yasuyuki Arakawa;Michio Sata;Shuhei Nishiguchi

  • Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial.

    Richard S. Finn;Philippe Merle;Alessandro Granito;Yi Hsiang Huang

  • Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial.

    Masatoshi Kudo;Kazuomi Ueshima;Osamu Yokosuka;Sadahisa Ogasawara

  • Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation.

    Tetsuhiro Chiba;Yun-Wen Zheng;Kaoru Kita;Osamu Yokosuka

  • Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study).

    Shiv Kumar Sarin;Ashok Choudhury;George K. Lau;Ming-Hua Zheng

  • De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes.

    Hitoshi Maruyama;Hidehiro Okugawa;Masanori Takahashi;Osamu Yokosuka

  • Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Tokyo-Chiba Hepatitis Research Group

    Y Shiratori;N Kato;O Yokosuka;F Imazeki

  • Resolution of acute hepatitis C after therapy with natural beta interferon.

    M. Omata;O. Yokosuka;S. Takano;N. Kato

Frequent Co-Authors

Fumio Imazeki
Fumio Imazeki Chiba University
Hiromitsu Saisho
Hiromitsu Saisho Chiba University
Masao Omata
Masao Omata University of Tokyo
Masaru Miyazaki
Masaru Miyazaki International University of Health and Welfare
Kunio Okuda
Kunio Okuda Chiba University
Masatoshi Kudo
Masatoshi Kudo Kindai University
Atsushi Iwama
Atsushi Iwama University of Tokyo
Shiv Kumar Sarin
Shiv Kumar Sarin Institute of Liver and Biliary Sciences
Michio Sata
Michio Sata Kurume University
George K. K. Lau
George K. K. Lau Humanity & Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn't always follow a traditional path. Many students consider what is the easiest nursing school to get into as a practical starting point, especially if they're seeking more accessible admission requirements and faster entry into the field.

For those who already have an RN license, most affordable accredited online rn to bsn programs offer a flexible way to advance your credentials and skills while balancing work or family commitments.

If you're from a non-nursing background but interested in healthcare, entry level msn programs online provide a unique opportunity to switch careers and quickly become a registered nurse with advanced qualifications.

Ambitious nurses may look toward leadership or teaching roles by pursuing a phd nursing education online, opening doors to research, academia, and advanced clinical practice. These pathways highlight the increasing accessibility and variety of online healthcare degrees for those pursuing a future in medicine.

Best Scientists Citing Osamu Yokosuka

Trending Scientists

Recently Published Articles